Patton Albertson Miller Group’s Elevance Health ELV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$297K Sell
769
-13
-2% -$4.82K 0.03% 186
2026
Q1
$229K Sell
782
-17
-2% -$5.59K 0.03% 200
2025
Q4
$280K Hold
799
0.03% 192
2025
Q3
$258K Sell
799
-1,616
-67% -$503K 0.03% 189
2025
Q2
$939K Buy
2,415
+5
+0.2% +$2.01K 0.12% 121
2025
Q1
$1.05M Hold
2,410
0.16% 113
2024
Q4
$889K Sell
2,410
-17
-0.7% -$7.11K 0.12% 119
2024
Q3
$1.26M Hold
2,427
0.17% 101
2024
Q2
$1.32M Buy
2,427
+1,567
+182% +$828K 0.19% 99
2024
Q1
$446K Sell
860
-25
-3% -$12.4K 0.07% 148
2023
Q4
$417K Sell
885
-9
-1% -$4.16K 0.07% 155
2023
Q3
$389K Buy
894
+11
+1% +$4.99K 0.08% 152
2023
Q2
$392K Sell
883
-75
-8% -$34.6K 0.08% 152
2023
Q1
$440K Hold
958
0.08% 159
2022
Q4
$491K Sell
958
-90
-9% -$45.7K 0.09% 161
2022
Q3
$476K Hold
1,048
0.1% 158
2022
Q2
$506K Sell
1,048
-95
-8% -$47K 0.1% 160
2022
Q1
$561K Sell
1,143
-95
-8% -$43.4K 0.1% 165
2021
Q4
$574K Hold
1,238
0.09% 171
2021
Q3
$462K Sell
1,238
-408
-25% -$155K 0.09% 177
2021
Q2
$628K Sell
1,646
-7
-0.4% -$2.67K 0.14% 126
2021
Q1
$593K Sell
1,653
-50
-3% -$16.1K 0.14% 129
2020
Q4
$493K Sell
1,703
-40
-2% -$12.3K 0.12% 145
2020
Q3
$468K Sell
1,743
-168
-9% -$45.2K 0.13% 146
2020
Q2
$503K Hold
1,911
0.15% 141
2020
Q1
$434K Sell
1,911
-75
-4% -$20.4K 0.15% 144
2019
Q4
$600K Sell
1,986
-72
-3% -$19.8K 0.16% 138
2019
Q3
$494K Sell
2,058
-533
-21% -$146K 0.14% 158
2019
Q2
$744K Buy
2,591
+192
+8% +$52.4K 0.21% 126
2019
Q1
$688K Sell
2,399
-170
-7% -$49.2K 0.35% 76
2018
Q4
$776K Hold
2,569
0.41% 64
2018
Q3
$682K Sell
2,569
-53
-2% -$13.8K 0.35% 79
2018
Q2
$624K Buy
2,622
+246
+10% +$57K 0.31% 83
2018
Q1
$522K Sell
2,376
-535
-18% -$126K 0.23% 86
2017
Q4
$655K Sell
2,911
-120
-4% -$25.6K 0.27% 87
2017
Q3
$585K Sell
3,031
-145
-5% -$27.6K 0.26% 92
2017
Q2
$593K Sell
3,176
-1,128
-26% -$203K 0.26% 89
2017
Q1
$765K Sell
4,304
-4,623
-52% -$735K 0.32% 84
2016
Q4
$1.28M Sell
8,927
-420
-4% -$56.2K 0.55% 58
2016
Q3
$1.17M Sell
9,347
-1,149
-11% -$148K 0.52% 61
2016
Q2
$1.38M Sell
10,496
-2,115
-17% -$289K 0.62% 48
2016
Q1
$1.75M Sell
12,611
-264
-2% -$35.3K 0.88% 37
2015
Q4
$1.79M Sell
12,875
-590
-4% -$81.3K 0.9% 38
2015
Q3
$1.88M Sell
13,465
-6,455
-32% -$970K 1% 34
2015
Q2
$3.27M Sell
19,920
-3,705
-16% -$592K 1.43% 20
2015
Q1
$3.65M Buy
+23,625
New +$3.36M 1.48% 10
2014
Q4
Sell
-29,767
Closed -$3.6M 149
2014
Q3
$3.6M Sell
29,767
-10,437
-26% -$1.2M 1.88% 7
2014
Q2
$4.32M Sell
40,204
-3,159
-7% -$325K 2.19% 4
2014
Q1
$4.32M Sell
43,363
-2,457
-5% -$222K 2.28% 8
2013
Q4
$4.23M Sell
45,820
-371
-0.8% -$33K 2.49% 8
2013
Q3
$3.86M Buy
46,191
+400
+0.9% +$34.3K 2.3% 10
2013
Q2
$3.75M Buy
+45,791
New +$3.43M 2.27% 10

Other funds holding ELV

Patton Albertson Miller Group's ELV Position: Q2 2026 in Review

Patton Albertson Miller Group reduced its Elevance Health (ELV) stake by 1.7% in Q2 2026, selling an estimated $4.82K and leaving 769 shares worth $297K. The position accounts for 0.03% of the portfolio, ranked #186.

Patton Albertson Miller Group first reported a position in ELV in Q2 2013 and has held it in 52 quarters since. The position peaked at $4.32M in Q2 2014. 423 funds tracked by Wall St. Rank hold ELV as of Q2 2026.

  • Patton Albertson Miller Group held 769 shares of Elevance Health worth $297K as of Q2 2026.
  • Patton Albertson Miller Group sold 13 Elevance Health shares in Q2 2026, an estimated $4.82K.
  • Elevance Health made up 0.03% of Patton Albertson Miller Group's portfolio in Q2 2026, its #186 holding.
  • Patton Albertson Miller Group first reported a position in Elevance Health in Q2 2013 and has held it in 52 quarters since.
  • Patton Albertson Miller Group's Elevance Health position peaked at $4.32M in Q2 2014.
  • 423 funds tracked by Wall St. Rank held Elevance Health as of Q2 2026.

Based on Patton Albertson Miller Group's 13F filing for Q2 2026, filed 22 Jul 2026.